Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Eating too much ultra-processed food? A study links it to worse PMS symptoms

10

Nov 2026

Eating too much ultra-processed food? A study links it to worse PMS symptoms

A cross-sectional study of 607 young adult women in Turkey found that higher ultra-processed food consumption scores were associated with more severe premenstrual syndrome (PMS) symptoms, while non-judgmental and non-reactive mindful eating behaviors were linked to lower symptom severity. Mediterranean diet adherence was not independently associated with PMS severity, and the researchers cautioned that the findings cannot establish cause and effect.

Could eating more mushrooms help protect your brain as you age?

10

Nov 2026

Could eating more mushrooms help protect your brain as you age?

A review of existing research suggests that ergothioneine, a natural antioxidant found primarily in mushrooms, may protect brain cells against oxidative stress, inflammation, and damage associated with Alzheimer's and Parkinson's diseases. Although laboratory and animal studies show promising neuroprotective effects, human evidence remains limited, and larger clinical trials are needed to determine whether supplementation can prevent or slow neurodegeneration.

Artery scans detect “silent atherosclerosis” in 1 in 13 adults under 30

10

Nov 2026

Artery scans detect “silent atherosclerosis” in 1 in 13 adults under 30

Researchers studying 16,808 adults aged 18 to 70 found that silent atherosclerosis was detectable in early adulthood, with plaque present in 57.1% of those who completed imaging across three arterial territories. Plaque prevalence and burden were higher in older age groups, with men showing earlier evidence of disease than women, while conventional cardiovascular risk scores identified relatively few people with existing plaque.

The gap between male and female runners is shrinking. What's driving it?

10

Nov 2026

The gap between male and female runners is shrinking. What's driving it?

A study of 13,094 performances by 3,611 elite runners across 11 running disciplines found that the performance gap between women and men narrowed from 13.2% in 2001 to 11.9% in 2025. Women improved approximately twice as much as men, with the greatest relative gains in middle- and long-distance races, challenging the longstanding assumption that the gap had stabilized.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.